Study Stopped
Monocentric Study, Site reorganised, could no longer participate in study
Post-market Follow up Study of the 'BPK-S Integration' UC as Primary Implant in the Variants CoCr or Ceramic
Prospective, Open, Non-randomized, Non-interventional Explorative, Comparative, Uncontrolled Cohort Study for Post Market Clinical Follow-Up of the "BPK-S Integration" UC in the Variants CoCr or Ceramic as Primary Implant
1 other identifier
observational
28
1 country
1
Brief Summary
Prospective Post-Market Clinical Follow up study according to MEDDEV 2.12/2 rev2 of the European Union. Patients receiving the primary knee implant BPK-S UC as primary implant in either variant ceramic or CoCr (metal) are eligible for the study and will be followed up for 5 years after implantation or until revision of the prosthesis, whichever occurs first. Demographic data will be collected together with data regarding safety and benefit at defined timepoints (preoperative, intraoperative and at 3 months, 1 year, 2 years and 5 years after implantation). Patients will be divided in 2 cohorts (ceramic and metal) and stratified by age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2017
CompletedFirst Posted
Study publicly available on registry
September 26, 2017
CompletedStudy Start
First participant enrolled
March 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 14, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 14, 2019
CompletedNovember 19, 2019
November 1, 2019
1.6 years
September 19, 2017
November 15, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Patient relevant benefit after 5 years
improvement of KSS-Score by at least one category as compared to preoperative basic assessment
5 years
Secondary Outcomes (7)
Patient relevant benefit as measured by American Knee Society Score
3 months, 1, 2 and 5 years
Patient relevant benefit as measured by Knee Osteoarthritis Outcome Score
3 months, 1, 2 and 5 years
Patient Quality of Life
3 months, 1, 2 and 5 years
Implant Loosening Number
3 months, 1, 2 and 5 years
Implant Loosening Reason
3 months, 1, 2 and 5 years
- +2 more secondary outcomes
Study Arms (2)
Ceramic
Patients receiving BPK-S Integration UC implant made from BIOLOX delta ceramic
CoCr
Patients receiving BPK-S Integration UC implant made from CoCr (metal)
Interventions
Eligibility Criteria
Patients undergoing primary total knee endoprosthesis with BPK-S Integration of age 18 and older
You may qualify if:
- Congenital or acquired knee joint defects/deformation
- Defects or malfunction of the knee joint
- Arthrosis (degenerative, rheumatic)
- Post-traumatic arthritis
- Symptomatic knee instability
- Reconstruction of flexibility
- Patients with metal hypersensitivity (ceramic tibia/femur)
You may not qualify if:
- Illnesses which can be treated without using a knee joint implant.
- Acute or chronic infections near the implantation
- Systemic diseases and metabolic disorders
- Serious osteoporosis
- Serious damage to the bone structures that impedes stable implantation of the implant components
- Diseases that impair bone growth, e.g. cancer, renal dialysis, osteopenia, etc.
- Bone tumors in the area of the implant anchoring
- Obesity or overweight of the patient
- Overload of the knee implant to be expected
- Abuse of medication, drug abuse, alcoholism or mental disease
- Pregnancy
- Lack of patient cooperation
- Sensitivity to foreign matter in the implant materials
- Patients under the age of 18
- Patients participating in another trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peter Brehm GmbHlead
- P.R.I.S.M.A.-CROcollaborator
Study Sites (1)
SMZ Ost, Donauspital
Vienna, Upper Austria, 1220, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian E. Berger, Prof.
Sozialmedizinisches Zentrum Ost - Donauspital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2017
First Posted
September 26, 2017
Study Start
March 20, 2018
Primary Completion
October 14, 2019
Study Completion
October 14, 2019
Last Updated
November 19, 2019
Record last verified: 2019-11